To evaluate serum neurofilament light chain (sNfL) as biomarker of disease onset, progression and treatment effect in hereditary transthyretin (ATTRv) amyloidosis patients and TTR variant ( T
Data are expressed as n (%) or mean ± standard deviation. OSA, obstructive sleep apnea; SaO2, oxygen saturation.Baseline characteristics of the study subjects.
